Epigenomics AG
ECX | F
Overview
Corporate Details
- ISIN(s):
- DE000A37FT41 (+2 more)
- LEI:
- 549300X1C4U862NDLN97
- Country:
- Germany
- Address:
- Bertha-Benz-Str. 5, 10557 Berlin
- Website:
- https://www.epigenomics.com/
- Sector:
- Health Care
- Industry:
- Health Care Equipment & Supplies
Description
We revolutionize the way of cancer diagnostics using our unique, proprietary DNA methylation biomarker technology. Epigenomics develops and commercializes patient-friendly, blood-based diagnostic tests across multiple cancer indications with high medical need. Using blood as a liquid biopsy can improve patient access to cancer screening and thereby contribute to eradicate today’s deadliest cancer types such as colorectal, liver, and lung cancer. By leveraging our product pipeline and strong intellectual property, we aim to become a global leader in blood-based cancer detection.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-04-28 10:17 |
Regulatory News Service
|
English | 3.6 KB | |
| 2025-04-23 11:29 |
Earnings Release
Epigenomics AG: Jahresergebnis zum 31. Dezember 2024 und Prognoseabweichung
|
German | 7.4 KB | |
| 2025-01-22 15:05 |
Earnings Release
Epigenomics AG: Vorlaufiges Jahresergebnis zum 31. Dezember 2024
|
German | 8.4 KB | |
| 2025-01-21 15:05 |
Earnings Release
Epigenomics AG: Vorlaufiges Jahresergebnis zum 31. Dezember 2024
|
German | 8.4 KB | |
| 2024-03-12 00:00 |
Annual Report
|
German | 2.5 MB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-12-27 | Ho, Dr. Selwyn | Board | Buy | None | 4,200.00 EUR |
| 2022-12-23 | von Prondzynski, Heino | Supervisory board | Buy | None | 5,625.00 EUR |
| 2022-12-22 | Ahlers, Felix | Board | Other | None | 22,000.00 EUR |
| 2022-12-22 | Lubenow, Dr. Helge | Supervisory board | Buy | None | 1,934.20 EUR |
| 2022-12-20 | von Prondzynski, Heino | Supervisory board | Buy | None | 3,680.00 EUR |
| 2022-12-16 | Lindenice GmbH | Board | Buy | None | 7,400.00 EUR |
| 2022-12-16 | Ho, Dr. Selwyn | Board | Buy | None | 6,780.00 EUR |
| 2022-12-14 | von Prondzynski, Heino | Supervisory board | Buy | None | 40,000.00 EUR |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Metrics in Balance N.V. | Belgium | MLMIB | |
|
Micropos Medical AB | Sweden | MPOS | |
| Milestone Medical | United States of America | MMD | ||
|
Milton Essex Spolka Akcyjna | Poland | MTN | |
|
Momina Krepost AD | Bulgaria | MKR | |
|
Monivent AB | Sweden | MONI | |
| Mydas Real Estate Investments Ltd. | Israel | MYDS | ||
|
NanoEcho AB | Sweden | NANECH | |
|
Nasmed Ozel Saglik Hizmetleri Ticaret AS | Türkiye | EGEPO | |
|
NeoDynamics AB | Sweden | NEOD |